09:51 EDT RAPT Therapeutics (RAPT) trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RAPT:
- Rapt Therapeutics, Jeyou announce data from Phase 2 trial of RPT904
- Rapt Therapeutics initiated with an Overweight at Barclays
- RAPT Therapeutics: Anticipated Catalysts and Growth Potential Drive Buy Rating
- Rapt Therapeutics price target raised to $41 from $24 at Clear Street
- Rapt Therapeutics: FDA clears IND application for Phase 2b trial of RPT904